
The anti-CD19/CD20 CAR T-cell therapy will be studied in the phase 2 ABZT-121 trial after progression on commercial CAR T-cell therapy.
Justin Kaner, MD, discusses the latest advances surrounding menin inhibitors in acute myeloid leukemia.
Justin Kaner, MD, discusses the latest advances surrounding menin inhibitors in acute myeloid leukemia.

